|
The
Manitoba
Drug Benefits and Interchangeability Formulary lists therapeutically effective drugs
of proven high quality that have been approved as eligible benefits
under the
Pharmacare drug benefit program. It also includes a list of
interchangeable drugs. It is compiled with the advice
of the Manitoba Drug Standards and Therapeutics
Committee, assisted by
Manitoba Health staff and outside consultants. The Minister
of Health gives the final approval for benefits under the
Pharmacare drug benefit program.
Updates to the Manitoba Formulary are made available every three
to four months by bulletin and via this website. Copies
of the Manitoba Formulary and the updates are also available at
the Queen’s
Printer (Manitoba) Statutory Publications, 200 Vaughan Street,
Winnipeg, Manitoba, R3C 1T5, telephone (204) 945-3101 in Winnipeg,
toll free 1-800-231-1203, fax (204) 945-7172. Note: In
the case of discrepancies between the versions of documents on
this website and the official versions as published by the Queen’s
Printer (Manitoba) Statutory Publications, the official versions
will prevail.
Each new Formulary has three components: a new Bulletin,
a revised Specified Drugs Regulation (Parts 1 and 2) made
under The Prescription Drugs Cost Assistance Act,
and a revised Manitoba Drug Interchangeability Formulary.
A listing of pharmaceutical manufacturer abbreviations is also
provided below.
These documents require knowledgeable interpretation and are
intended primarily for use by professional health care practitioners,
pharmacies, hospitals, and organizations associated with the
manufacture, distribution and use of pharmaceutical preparations.
Please note: you will
need the Adobe Acrobat Reader to view PDF documents.
If you do not have the Adobe Acrobat Reader installed on your computer,
please click here:
|
|
Bulletin
#53
Amendments to the
Manitoba Drug Benefits and Interchangeability Formulary.
Effective Date: December 14, 2006
|
|
|
This is the regulation
that provides for the benefit lists of specified drugs
under the
Prescription Drugs
Cost Assistance Act.
It lists the drugs and criteria for eligibility
for the Manitoba Pharmacare program.
Effective Date: September 14, 2006 |
|
|
This regulation
includes a list of interchangeable drugs, categories
and prices under The
Pharmaceutical Act.
Please note that Manitoba Pharmacare will reimburse
only up to the level of the lowest price in
an interchangeable category for those interchangeable
drugs which are Pharmacare benefits.
Effective Date: September
14, 2006 |
|
|
Changes
to Pharmacare & Family Services Drug Programs benefit
coverage for Proton Pump Inhibitors effective March
13, 2006
Since their introduction,
Proton Pump Inhibitors (PPIs) have been in increasing
demand. Although they are extremely effective medications,
the wide spread use of PPIs exerts significant cost
pressure on Pharmacare and Family Services Drug Programs
and on consumers. As a result, Pharmacare and Family
Services Drug Programs are changing the way they provide
benefit coverage of the PPIs.
Effective Date: March 13, 2006 |
|
|
Information
Sheet for Health Professionals - Move Into Part 3
Exception Drug Status (Eds) Proton Pump Inhibitors
(PPI’s) For Pharmacare And Family Services Clients
Effective March 13, 2006, all Pharmacare and Family
Services Drug Program clients being started on a
PPI will require Part 3 Exception Drug Status (EDS)
approval to receive drug program benefits.
Effective Date: March 13, 2006 |
|
|
|
An index of pharmaceutical manufacturer abbreviations
used in the Manitoba Drug Interchangeability Formulary.
Revised: October, 2005
8 pages |
|
|
Changes to Pharmacare benefit coverage for COX-2 Inhibitors Effective September 1, 2004, Pharmacare will implement a
change in the benefit status for the class of COX-2 drugs (Celebrex,
Mobicox and Vioxx generic meloxicam), from Part 2 to Part 3.
COX-2 Inhibitors will be required to meet established EDS
criteria for the treatment of osteoarthritis and rheumatoid
arthritis.
Effective Date: September 1, 2004
|
|
|
A product identification listing for non-prescription
products.
Revised:
September 2003
7 pages |
|
(Veuillez
noter que les documents sont offert en anglais seulement.)
|
For more information,
please contact:
Provincial Drug Programs
Manitoba Health
300 Carlton Street
Winnipeg MB R3B 3M9
Phone: (204) 786-7318
|
|
|